Somewhat Positive Press Coverage Somewhat Unlikely to Affect Analogic (ALOG) Share Price

Media headlines about Analogic (NASDAQ:ALOG) have trended somewhat positive on Saturday, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Analogic earned a news sentiment score of 0.20 on Accern’s scale. Accern also gave headlines about the medical research company an impact score of 47.5117687811454 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

A number of research analysts have recently issued reports on the company. BidaskClub downgraded Analogic from a “sell” rating to a “strong sell” rating in a research note on Saturday, January 6th. Zacks Investment Research raised Analogic from a “hold” rating to a “strong-buy” rating and set a $108.00 price objective on the stock in a research note on Thursday, March 8th. Finally, Jefferies Group reissued a “hold” rating and issued a $80.00 price objective on shares of Analogic in a research note on Friday, December 8th.

How to Become a New Pot Stock Millionaire

Analogic (ALOG) opened at $93.50 on Friday. The stock has a market capitalization of $1,169.48, a PE ratio of -16.15, a PEG ratio of 3.16 and a beta of 0.77. Analogic has a 52 week low of $66.00 and a 52 week high of $101.80.

Analogic (NASDAQ:ALOG) last announced its quarterly earnings data on Monday, March 5th. The medical research company reported $1.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.58. The company had revenue of $129.20 million for the quarter, compared to the consensus estimate of $112.50 million. Analogic had a positive return on equity of 6.05% and a negative net margin of 15.34%. The firm’s revenue was down 1.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.99 EPS. equities research analysts anticipate that Analogic will post 4.23 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, March 26th. Investors of record on Thursday, March 15th will be given a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 0.43%. The ex-dividend date is Wednesday, March 14th. Analogic’s payout ratio is -6.91%.

COPYRIGHT VIOLATION NOTICE: This news story was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another site, it was illegally stolen and reposted in violation of United States and international copyright laws. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3270744/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-analogic-alog-share-price.html.

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Insider Buying and Selling by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Essilor International  Given a €104.40 Price Target at JPMorgan Chase
Essilor International Given a €104.40 Price Target at JPMorgan Chase
Berenberg Bank Analysts Give Danone  a €72.50 Price Target
Berenberg Bank Analysts Give Danone a €72.50 Price Target
Zooplus  Given a €140.00 Price Target by Kepler Capital Markets Analysts
Zooplus Given a €140.00 Price Target by Kepler Capital Markets Analysts
Reviewing Government Properties Income Trust  and Innovative Industrial
Reviewing Government Properties Income Trust and Innovative Industrial
Sky Solar  & Its Rivals Head-To-Head Comparison
Sky Solar & Its Rivals Head-To-Head Comparison
Analyzing Calyxt  & The Competition
Analyzing Calyxt & The Competition


© 2006-2018 Ticker Report. Google+.